Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XLC vs MRNA✓SelectedUSD · MRNAXLC vs MRNA performance historyLatest closeAs of-1.46%11/17
Stock and ETF performance explorer

XLC vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+37.8%
MRNA return
-11.9%
Excess return
+49.7%
Maximum drawdown
-43.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.5%-3.9%+2.5%-1.3%
7D-2.3%-17.6%+15.2%-1.5%
30D-4.6%-5.1%+0.6%-4.5%
3M-4.7%+220.8%-225.5%-12.3%
6M-8.8%+321.7%-330.5%-18.9%
YTD-9.8%+601.3%-611.0%-24.7%
1Y-4.2%+735.2%-739.4%-21.8%
3Y+55.5%+170.5%-115.0%+36.4%
5Y+37.8%-14.6%+52.4%+28.9%
All+37.8%-11.9%+49.7%+28.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling